GSK, Actavis Dodge RICO Claims In Testosterone Case

An Illinois federal judge freed pharmaceutical giants GlaxoSmithKline and Actavis on Tuesday from having to face racketeering charges in a suit accusing them and other drugmakers of a fraudulent marketing scheme that led health insurers to pay for medically unnecessary testosterone replacement drugs.